These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25242682)

  • 41. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
    Molinaro E; Romei C; Biagini A; Sabini E; Agate L; Mazzeo S; Materazzi G; Sellari-Franceschini S; Ribechini A; Torregrossa L; Basolo F; Vitti P; Elisei R
    Nat Rev Endocrinol; 2017 Nov; 13(11):644-660. PubMed ID: 28707679
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis and Management of Anaplastic Thyroid Cancer.
    Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of combined treatment for anaplastic thyroid carcinoma: results of a multinstitutional retrospective analysis.
    Conzo G; Polistena A; Calò PG; Bononi P; Gambardella C; Mauriello C; Tartaglia E; Avenia S; Sanguinetti A; Medas F; de Toma G; Avenia N
    Int J Surg; 2014; 12 Suppl 1():S178-82. PubMed ID: 24866070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid.
    Sugitani I; Kasai N; Fujimoto Y; Yanagisawa A
    World J Surg; 2001 May; 25(5):617-22. PubMed ID: 11369989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaplastic Thyroid Cancer Arising from Dyshormonogenetic Goiter: c.3070T>C and Novel c.7070T>C Mutation in the Thyroglobulin Gene.
    Yoon JH; Hong AR; Kim HK; Kang HC
    Thyroid; 2020 Nov; 30(11):1676-1680. PubMed ID: 32633627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma: a 20-year single-center retrospective study].
    Wei YC; Zhang D; Chai Y; Dong M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Mar; 58(3):218-224. PubMed ID: 36878500
    [No Abstract]   [Full Text] [Related]  

  • 48. Socioeconomic Factors Affect Outcomes in Well-Differentiated Thyroid Cancer.
    Swegal WC; Singer M; Peterson E; Feigelson HS; Kono SA; Snyder S; Melvin TA; Calzada G; Ghai NR; Saman DM; Chang SS
    Otolaryngol Head Neck Surg; 2016 Mar; 154(3):440-5. PubMed ID: 26671905
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of targeted therapy and/or immunotherapy therapy in anaplastic thyroid carcinoma.
    Wu G; Song Y; Yang S; Li H; Liu S; Gui L; Ni S
    Endocrine; 2024 Jun; 84(3):1013-1020. PubMed ID: 38146047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic factors in well-differentiated thyroid carcinoma.
    Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors of anaplastic thyroid carcinoma.
    Jiang JY; Tseng FY
    J Endocrinol Invest; 2006 Jan; 29(1):11-7. PubMed ID: 16553028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer.
    Cabanillas ME; Williams MD; Gunn GB; Weitzman SP; Burke L; Busaidy NL; Ying AK; Yiin YH; William WN; Lu C; Lai SY
    Head Neck; 2017 Jul; 39(7):1291-1295. PubMed ID: 28452157
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Case-control study of anaplastic thyroid cancer: goiter patients as controls.
    Zivaljevic VR; Vlajinac HD; Marinkovic JM; Kalezic NK; Paunovic IR; Diklic AD
    Eur J Cancer Prev; 2008 Apr; 17(2):111-5. PubMed ID: 18287867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Anaplastic carcinoma of the thyroid: long-term survival].
    Cannizzaro MA; De Maria A; Fazzi C; Mazzone G; Terminella A; Fiorenza G; Veroux PF
    Minerva Chir; 1993 Nov; 48(21-22):1293-9. PubMed ID: 8152560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer.
    Zhang L; Luo H; Wang L; Liu Y; Rui S; Wu Z; Wei T; Gong R; Li Z; Zhu J
    J Surg Oncol; 2020 Oct; 122(5):897-905. PubMed ID: 32596828
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
    McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
    Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Perspectives Regarding Anaplastic Thyroid Carcinoma Approach Improvement.
    Figueiredo AS; Andrea-Ferreira P
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):555-564. PubMed ID: 29886838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
    Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
    Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy.
    Lennon P; Deady S; Healy ML; Toner M; Kinsella J; Timon CI; O'Neill JP
    Head Neck; 2016 Apr; 38 Suppl 1():E1122-9. PubMed ID: 26879282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
    Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
    Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.